SNAI2 and gastric cancer: miR-2392 targets the regulatory operator-like protein 3 (MAML3) and NSD histone methyltransferase 1 (WHSC1) to inhibit the expression of the transcription factors Slug/Twist1 and block gastric cancer cell metastasis in vivo and in vitro [106].